Knowledge Tree
Relations (1)
related 2.58 — strongly supporting 5 facts
Ketamine and ibogaine are both categorized as non-classic hallucinogens [1] and psychoactive substances that are frequently studied alongside classic psychedelics for their potential in psychiatric treatment [2], [3], and [4]. Research frameworks developed for classic psychedelics are often applied to both compounds as novel therapeutic agents [5].
Facts (5)
Sources
Neuroimaging in psychedelic drug development: past, present, and ... nature.com 3 facts
claimWhile the authors focused their study outlines on 5-HT2AR agonist 'classic' psychedelics like psilocybin, LSD, and DMT, these study frameworks could be applied to other novel therapies such as ketamine, MDMA, and ibogaine.
claimKetamine, 3,4-Methylenedioxymethamphetamine (MDMA), and ibogaine are psychoactive substances that hold promise for psychiatric treatment alongside classic serotonergic psychedelics.
claimModern research into classic psychedelics and related compounds includes the study of LSD, psilocybin, N,N-Dimethyltryptamine (DMT), MDMA, ketamine, and ibogaine.
History and Current Status of Psychedelics and Entactogens ... - NCBI ncbi.nlm.nih.gov 1 fact
claimNon-classic hallucinogens include MDMA (also known as ecstasy or molly), ketamine, and ibogaine, according to Charles Grob.
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org 1 fact
claimWhile some experts define the term 'psychedelic' specifically as agonists of serotonin 2A receptors (such as psilocybin), psychedelic treatment models have been applied to diverse psychoactive drugs including MDMA, ibogaine, cannabis, and ketamine.